Angiographic Comparison in an Observational Study of CADence (The AMBIENCE Study)

NCT ID: NCT02515825

Last Updated: 2021-04-08

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

101 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-05-31

Study Completion Date

2016-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a prospective, multi-center study to capture information on sensitivity and specificity of CADence using coronary angiogram as the gold standard, on subjects who are already scheduled for coronary angiography.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

CADence is an ECG and acoustic tool to assess coronary artery disease. This study's goal is to collect patient CADence information and compare it to the results of angiogram to determine performance: sensitivity and specificity. The CADence is not used to direct patient care. This is observational only.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

AMBIENCE

CADence System testing followed by coronary angiogram

CADence

Intervention Type DEVICE

AMBIENCE plus R&R Substudy

CADence System testing for repeatibility and reproducibility (4x by 2 operators) followed by coronary angiogram

CADence

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CADence

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \>40 years
* Clinical indication for coronary angiogram
* Willing and able to give informed consent

Exclusion Criteria

* Body Mass Index (BMI) \<18.5 or \>40
* Prior bypass surgery or coronary stenting
* Presence of pacemaker/defibrillator
* Presence of artificial valve
* Presence of obvious cyanotic or pre-diagnosed congenital heart defect and coarctation of the aorta
* Presence of murmurs, including valve lesions, ventricular septal defects and arteriovenous fistulae
* Presence of moderate-severe valve disease
* Left Ventricular Assist Device (LVAD)
* Presence of scars on the site thorax areas
* Participation in trial within 30 days prior to collecting CADence data except participation in registry studies.
* Asthma or chronic obstructive pulmonary disease (COPD) with active wheezing
* Inability to lie in supine position
* Heart Transplant
Minimum Eligible Age

41 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AUM Cardiovascular, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Carmelo Panetta, MD

Role: STUDY_CHAIR

University of Minnesota

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Heart Center Research, LLC

Huntsville, Alabama, United States

Site Status

MedStar Union Memorial Hospital

Baltimore, Maryland, United States

Site Status

St. Joseph's Hospital

Saint Paul, Minnesota, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1217-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.